Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Total Dose and Fractionation on Clinical Outcomes of Low-Dose Radiotherapy for Heel Spur Syndrome: Optimal Radiotherapy - Heel Spur Syndrome (ORHEELS) Randomized Clinical Trial

NCT07546240 is registered in ClinicalTrials.gov with Maria Sklodowska-Curie National Research Institute of Oncology as lead sponsor.

NCT NCT07546240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07546240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Total Dose and Fractionation on Clinical Outcomes of Low-Dose Radiotherapy for Heel Spur Syndrome: Optimal Radiotherapy - Heel Spur Syndrome (ORHEELS) Randomized Clinical Trial
Lead sponsor
Maria Sklodowska-Curie National Research Institute of Oncology
Phase
Not applicable
Overall status
Recruiting
Start date
March 23, 2026
Completion date
March 22, 2030
Enrollment
366 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heel spur syndrome